REBECCA CRANDALL: Open Payments
NPI 1700051901 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 3 payments from 3 companies in 2025. Trend: 2023 $372 · 2024 $0 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 1 | $124 |
| Supernus Pharmaceuticals, Inc. | 1 | $119 |
| Janssen Pharmaceuticals, Inc | 1 | $119 |
Products named: Auvelity, Qelbree, INVEGA SUSTENNA.
Industry payments across CA — which companies pay providers there.
